BlackRock Advisors’s Biostage, Inc. Common Stock BSTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3K Hold
3,656
﹤0.01% 3672
2016
Q3
$4K Hold
3,656
﹤0.01% 3668
2016
Q2
$4K Hold
3,656
﹤0.01% 3694
2016
Q1
$7K Hold
3,656
﹤0.01% 3642
2015
Q4
$8K Hold
3,656
﹤0.01% 3668
2015
Q3
$3K Hold
3,656
﹤0.01% 3733
2015
Q2
$5K Sell
3,656
-106,308
-97% -$260K ﹤0.01% 3666
2015
Q1
$357K Hold
109,964
﹤0.01% 2329
2014
Q4
$350K Hold
109,964
﹤0.01% 2260
2014
Q3
$891K Sell
109,964
-4,337
-4% -$35.5K ﹤0.01% 1499
2014
Q2
$1.19M Sell
114,301
-4,066
-3% -$34.6K ﹤0.01% 1391
2014
Q1
$1.07M Buy
118,367
+4,282
+4% +$25.4K ﹤0.01% 1477
2013
Q4
$542K Buy
+114,085
New +$534K ﹤0.01% 1980

Other funds holding BSTG

BlackRock Advisors's BSTG Position: Q4 2016 in Review

BlackRock Advisors held its Biostage, Inc. Common Stock (BSTG) position steady in Q4 2016 at 3,656 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3672.

BlackRock Advisors first reported a position in BSTG in Q4 2013 and has held it in 13 quarters since. The position peaked at $1.19M in Q2 2014. 27 funds tracked by Wall St. Rank hold BSTG as of Q4 2016.

  • BlackRock Advisors held 3,656 shares of Biostage, Inc. Common Stock worth $3K as of Q4 2016.
  • BlackRock Advisors left its Biostage, Inc. Common Stock share count unchanged in Q4 2016.
  • Biostage, Inc. Common Stock made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3672 holding.
  • BlackRock Advisors first reported a position in Biostage, Inc. Common Stock in Q4 2013 and has held it in 13 quarters since.
  • BlackRock Advisors's Biostage, Inc. Common Stock position peaked at $1.19M in Q2 2014.
  • 27 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.